Abstract
Recently, we reported that induction of the co-chaperone Bcl-2-associated athanogene 3 (BAG3) is critical for recovery of rhabdomyosarcoma (RMS) cells after proteotoxic stress upon inhibition of the two constitutive protein degradation pathways, that is, the ubiquitin-proteasome system by Bortezomib and the aggresome-autophagy system by histone deacetylase 6 (HDAC6) inhibitor ST80. In the present study, we investigated the molecular mechanisms mediating BAG3 induction under these conditions. Here, we identify nuclear factor-kappa B (NF-κB)-inducing kinase (NIK) as a key mediator of ST80/Bortezomib-stimulated NF-κB activation and transcriptional upregulation of BAG3. ST80/Bortezomib cotreatment upregulates mRNA and protein expression of NIK, which is accompanied by an initial increase in histone H3 acetylation. Importantly, NIK silencing by siRNA abolishes NF-κB activation and BAG3 induction by ST80/Bortezomib. Furthermore, ST80/Bortezomib cotreatment stimulates NF-κB transcriptional activity and upregulates NF-κB target genes. Genetic inhibition of NF-κB by overexpression of dominant-negative IκBα superrepressor (IκBα-SR) or by knockdown of p65 blocks the ST80/Bortezomib-stimulated upregulation of BAG3 mRNA and protein expressi...Continue Reading
References
Jun 25, 1995·Nucleic Acids Research·L LombardiA Neri
Aug 7, 1998·Molecular Biology of the Cell·A M CuervoJ F Dice
Nov 21, 2007·Cell·James E VinceJohn Silke
Dec 7, 2007·Bioorganic & Medicinal Chemistry·Stefan SchäferManfred Jung
Apr 29, 2008·Biochemical and Biophysical Research Communications·Tobias Wittwer, M Lienhard Schmitz
Jul 23, 2008·Molecular Cancer Research : MCR·Gary K ScottChristopher C Benz
Sep 2, 2008·Autophagy·Daniel J KlionskyDavid C Rubinsztein
Nov 11, 2008·Nature Immunology·Brian J ZarnegarGenhong Cheng
Nov 14, 2008·Journal of Cellular Physiology·Zhen-Xian DuHua-Qin Wang
Feb 3, 2009·Cancer Letters·Victoria M RichonJames S Hardwick
Jun 9, 2009·Autophagy·Mathieu NivonCarole Kretz-Remy
Sep 10, 2009·Journal of Biochemistry·Hiroshi Kubota
Aug 6, 2010·Cytokine & Growth Factor Reviews·Yee Mon Thu, Ann Richmond
Aug 26, 2010·Cancer Science·Mizuki YamamotoJun-Ichiro Inoue
Jul 21, 2011·Nature Immunology·Andrea OeckinghausSankar Ghosh
Aug 6, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Martin GamerdingerChristian Behl
Jan 20, 2012·Nature Reviews. Cancer·Neil D Perkins
Feb 4, 2012·Journal of Cell Science·Mathieu NivonCarole Kretz-Remy
Feb 22, 2012·Cell Death and Differentiation·P GonzalezS Fulda
Apr 21, 2012·International Journal of Cell Biology·Trond Lamark, Terje Johansen
Sep 13, 2012·Blood·Stella M RanuncoloBrian A Lewis
Oct 3, 2012·PloS One·Yu LiuKeqing Zhu
Dec 15, 2012·Molecular Endocrinology·Bingbing WangTodd Rosen
Mar 27, 2013·Resuscitation·Kyung Su KimYoung Ho Kwak
May 7, 2013·Oncogene·F RapinoS Fulda
Oct 3, 2013·The Journal of Biological Chemistry·Kyoung-Hee LeeChul-Gyu Yoo
Nov 30, 2013·Cell Death & Disease·I EckhardtS Fulda
Citations
Nov 26, 2015·FEBS Letters·Shulin GuiShi Liu
Jul 15, 2015·Cell Death & Disease·V FelzenT Morawe
May 11, 2016·Trends in Pharmacological Sciences·Christian Behl
May 2, 2017·Annual Review of Biochemistry·Ivan Dikic
Aug 16, 2017·Journal of Cell Science·Christina KlimekJörg Höhfeld
Jul 7, 2017·Frontiers in Molecular Neuroscience·Elisabeth Stürner, Christian Behl
Feb 28, 2018·Molecular Medicine Reports·Shasha YuYingxian Sun
Mar 19, 2019·Oncology Letters·Ting YuanXin Wang
Nov 8, 2020·Cells·Christof HiebelChristian Behl
Apr 13, 2021·Frontiers in Physiology·Qianghua XiaYongjie Wei